Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

2019 Alliance for Nanotechnology in Cancer Principal Investigators’ Meeting

September 24 – September 26, 2019

Add to Outlook Calendar

Day 1: Tuesday, September 24

Time

Session

8:30 – 9:00 a.m.

Welcome and Introduction

  • Doug Lowy, M.D., Acting Director, National Cancer Institute

  • Janet Eary, M.D., Associate Director, Cancer Imaging Program, DCTD, National Cancer Institute

  • Piotr Grodzinski, Ph.D., Branch Chief, NSDB/CIP/DCTD, National Cancer Institute

Session I

Moderator: Piotr Grodzinski, Ph.D., National Cancer Institute

9:00 – 9:35 a.m.

UCLA/Caltech/ISB Center Highlights and Takeaways

James Heath, Ph.D., Institute for Systems Biology

9:35 – 10:10 a.m.

MSKCC-Cornell Center Highlights and Takeaways

Michelle Bradbury, Ph.D, M.D., Memorial Sloan Kettering Cancer Center

10:10 – 10:30 a.m.

Break

10:30 – 11:15 a.m.

Keynote Presentation: Nanomedicine: Past, Present, and Future

Omid Farokhzad, M.D., M.B.A., Brigham and Women’s Hospital

11:15 a.m. – 12:00 p.m.

Keynote Presentation: Most Pressing Needs in Cancer Research and Oncology in Context of New Technology Development

Phuoc Tran, M.D., Ph.D., Johns Hopkins University

12:00 – 1:15 p.m.

Lunch

Session II

Moderator: Christopher Hartshorn, Ph.D., National Cancer Institute

1:15 – 1:35 p.m.

Effective Delivery of a Therapeutic Monoclonal Antibody to Metastases in the Central Nervous System of Mice Via Polymer Encapsulation and Receptor Targeting

Masakazu Kamata, Ph.D., UCLA

1:35 – 1:55 p.m.

Novel Approach to Attenuate Small Lung Cancer Growth and Metastasis

Wasim Nasser, Ph.D., University of Nebraska Medical Center

1:55 – 2:15 p.m.

Wireless Nano-Optogenetic Immunotherapy

Gang Han, Ph.D., University of Massachusetts Worchester

2:15 – 2:45 p.m.

Imaging the Delivery and Action of Nanomaterials in Vivo: An Update of MGH IRCN Progress

Miles Miller, Ph.D., Massachusetts General Hospital

2:45 – 3:15 p.m.

Break and Alliance Celebration

3:15 – 4:`35 p.m.

T32 Program Overviews

  • Jianghong Rao, Ph.D., Stanford University CNTC

  • Konstantin Sokolov, Ph.D., The University of Texas MD Anderson CNTC

  • Alexander Stegh, Ph.D., Northwestern University CNTC

  • Andrew Kummel, Ph.D., University of California, San Diego CNTC

  • Alexander Kabanov, Ph.D., The University of North Carolina at Chapel Hill CNTC

5:15 – 6:15 p.m.

Coordination and Governance Committee Meeting

By invitation only. Rm. 2W910

Day 2: Wednesday, September 25

Time

Session

Session III

Moderator: Christopher Hartshorn, Ph.D., National Cancer Institute

9:00 – 9:35 a.m.

UNC Chapel Hill Center Highlights and Takeaways

Leaf Huang, Ph.D., University of North Carolina at Chapel Hill

9:35 – 10:10 a.m.

WUSTL Center Highlights and Takeaways

Sam Achilefu, Ph.D., Washington University in St. Louis

10:10 – 10:30 a.m.

Break

10:30 – 11:05 a.m.

Northwestern Center Highlights and Takeaways 

Chad Mirkin, Ph.D., Northwestern University

11:05 – 11:35 a.m.

Use of a Silicasome Nanoparticle platform for Treatment of Pancreatic Ductal Adenocarcinoma

Huan Meng, Ph.D., UCLA

11:35 – 11:55 a.m.

Whitlockite Nanoparticle-based Immunotherapy for Bone Metastasis

Shiladitya Sengupta, Ph.D., Brigham and Women’s Hospital

11:55 a.m. – 1:10 p.m.

Lunch

Session IV

Moderator: Luisa Russell, Ph.D., National Cancer Institute

1:10 – 1:30 p.m.

UNC Clinical/Scientific Highlight Talk

Andrew Wang, M.D., University of North Carolina at Chapel Hill

1:30 – 1:50 p.m.

Northwestern Clinical/Scientific Highlight Talk – Spherical Nucleic Acid Nanotechnology for Cancer Immunotherapy: Advance to Clinical Evaluation and Rational Development of Vaccines

Andrew Lee, Ph.D., Northwestern University

1:50 – 2:10 p.m.

WUSTL Clinical/Scientific Highlight Talk

Gregory Lanza, M.D., Ph.D., Washington University in St. Louis

2:10 – 2:30 p.m.

Stanford Clinical/Scientific Highlight Talk

Alice Fan, M.D., Stanford University

2:30 – 2:50 p.m.

MSKCC-Cornell Clinical/Scientific Highlight Talk

Michelle Bradbury, Ph.D., M.D., Memorial Sloan Kettering Cancer Center

2:50 – 3:10 p.m.

UCLA/Caltech/ISB Clinical/Scientific Highlight Talk

Wei Wei, Ph.D., Institute for Systems Biology

3:10 – 3:30 p.m.

Break

3:30 – 3:50 p.m.

Nanoparticles for the Treatment of Intraperitoneal Mesothelioma: Enhancing Tumor Localization and Increasing Drug-Loading for Improved Efficacy

Mark Grinstaff, Ph.D., Boston University

3:50 – 4:20 p.m.

The Rodent Eye as a Non-invasive Window for Understanding Cancer Nanotherapeutics

Kit Lam, Ph.D., UC Davis

4:20 – 4:40 p.m.

Folate-Displaying Exosome Mediated Cytosolic Delivery of siRNA Avoiding Endosome Trapping

Peixuan Guo, Ph.D., Ohio State

4:40 – 5:00 p.m.

Alliance Achievements by the Numbers

Piotr Grodzinski, Ph.D., National Cancer Institute

5:00 – 6:00 p.m.

Poster Session, 2nd Floor Atrium

Day 3, Thursday, September 26

Time

Session

Session V

Moderator: Christina Liu, Ph.D. P.E., National Cancer Institute

9:00 – 9:35 a.m.

Stanford Center Highlights and Takeaways

Shan Wang, Ph.D., Stanford University

9:35 – 10:05 a.m.

Nanostructure-Embedded Microchips for Liquid Biopsy in Cancer

  • Hsian Rong Tseng, Ph.D., UCLA

  • Edwin Posadas, M.D., Cedars-Sinai Medical Center

10:05 – 10:25 a.m.

Break

10:25 – 10:55 a.m.

Targeted Core Shell Nanogels for Triple Negative Breast Cancer

Alexander Kabanov, Ph.D., University of North Carolina at Chapel Hill

10:55 – 11:25 a.m.

Co-delivery of Targeted Stroma-breaking Theranostic Nanoparticle and Immune Checkpoint Nano-PD-L1 Inhibitor for the Treatment of Pancreatic Cancer

Lily Yang, M.D., Ph.D., Emory University

11:25 – 11:55 a.m.

Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers

Wenbin Lin, Ph.D., University of Chicago

11:55 p.m. – 12:25 p.m.

Delivery of Drugs to Brain Tumors Using Multicomponent Nanoparticles

Efstathios Karathanasis, Ph.D., Case Western Reserve University

12:25 – 12:55 p.m.

Poster Prizes and Closing Comments

Piotr Grodzinski, Ph.D., National Cancer Institute

1:00 p.m.

Adjournment

Email